EPAS1 and Sepsis: In sepsis, LPS suppresses Sirt3 expression, which disrupts angiopoietins/Tie-2 and HIF-2α/Notch3 signaling pathways; thus leading to a reduction of pericyte/capillary coverage, subsequently promoting vascular leakage, inflammation and end-organ dysfunction (Fig. 8).